Your browser doesn't support javascript.
loading
CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphoma.
Takahashi, Koichi; Sivina, Mariela; Hoellenriegel, Julia; Oki, Yasuhiro; Hagemeister, Fredrick B; Fayad, Luis; Romaguera, Jorge E; Fowler, Nathan; Fanale, Michelle A; Kwak, Larry W; Samaniego, Felipe; Neelapu, Sattva; Xiao, Lianchun; Huang, Xuelin; Kantarjian, Hagop; Keating, Michael J; Wierda, William; Fu, Kai; Chan, Wing C; Vose, Julie M; O'Brien, Susan; Davis, Richard E; Burger, Jan A.
Afiliação
  • Takahashi K; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Sivina M; Department of Haematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Hoellenriegel J; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Oki Y; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Hagemeister FB; Department of Lymphoma and Myeloma, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Fayad L; Department of Lymphoma and Myeloma, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Romaguera JE; Department of Lymphoma and Myeloma, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Fowler N; Department of Lymphoma and Myeloma, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Fanale MA; Department of Lymphoma and Myeloma, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Kwak LW; Department of Lymphoma and Myeloma, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Samaniego F; Department of Lymphoma and Myeloma, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Neelapu S; Department of Lymphoma and Myeloma, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Xiao L; Department of Lymphoma and Myeloma, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Huang X; Department of Biostatistics, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Kantarjian H; Department of Biostatistics, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Keating MJ; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Wierda W; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Fu K; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Chan WC; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA.
  • Vose JM; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA.
  • O'Brien S; Division of Oncology and Hematology, University of NebraskaMedical Center, Omaha, NE, USA.
  • Davis RE; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Burger JA; Department of Lymphoma and Myeloma, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
Br J Haematol ; 171(5): 726-35, 2015 Dec.
Article em En | MEDLINE | ID: mdl-26358140
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Linfoma Difuso de Grandes Células B / Receptor do Fator Ativador de Células B / Quimiocina CCL3 / Quimiocina CCL4 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Linfoma Difuso de Grandes Células B / Receptor do Fator Ativador de Células B / Quimiocina CCL3 / Quimiocina CCL4 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos